Skip to main content
. 2012 Mar;165(6):1827–1835. doi: 10.1111/j.1476-5381.2011.01668.x

Figure 1.

Figure 1

Inhibitory effects of F 16618 on SFLLR-induced human washed platelet aggregation. Platelets were pre-incubated with various concentrations of F 16618 and stimulated with SFLLR 0.1– 50 µM for 5 min. (A) and (B) SFLLR-induced platelet aggregation in the presence of F 16618 (2.5, 5 and 7.5 µM). The percentage of the mean Emax is shown in (A), and the corresponding Schild plot is presented in (B), for the calculation of pA2. (C) SFLLR (1.5 µM)-induced platelet aggregation was significantly inhibited by F 16618 (2, 3 and 4 µM). Each point represents the mean of duplicate tests, and the horizontal bar represents the mean value. (D) SFLLR (1.5 µM)-induced platelet aggregation expressed as the percentage of mean Emax used to calculate the IC50 value. ***P < 0.001 versus untreated group.